Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
Hereditary Infantile Hemiparesis, Retinal Arteriolar Tortuosity, and Leukoencephalopathy
Neurol 60:57-63,8, Vahedi,K.,et al, 2003
Successful Treatment of Persistent Migraine Aura with Divalproex Sodium
Neurol 48:261-262, Rothrock,J.F., 1997
Persistent Positive Visual Phenomena in Migraine
Neurol 45:664-668, Liu,G.T.,et al, 1995
Benign Episodic Unilateral Mydriasis
Ophthalmol 102:1623-1627, Jacobson,D.M., 1995
Psychiatric Manifest of Systemic Lupus Erythematosus:Clin Features, Symptoms, & Signs of CNS Activity in 43 Pts
Medicine 73:224-232, Miguel,E.C.,et al, 1994
Permanent Cerebral Diplopia in a Migraineur
Neurol 40:1138-1139, Sinoff,S.E.&Rosenberg,M., 1990
Migraine-Related Stroke in the Context of the International Headache Society Classification of Head Pain
Arch Neurol 47:458-462, Welch,K.M.A.&Levine,S.R., 1990
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Amaurosis Fugax and Ocular Infarction in Adolescents and Young Adults
Ann Neurol 26:69-77, Tippin,J.,et al, 1989
The Fortification Spectra of Migraine
BMJ 293:1613-1617, Plant,G.T., 1987
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Vascular Retinopathy in Migraines
Neurol 36:267-270, Coppeto,F.R.,et al, 1986
Late-Life Migraine Accompaniments-Further Experience
Stroke 17:1033-1042, Fisher,C.M., 1986
Migrainous Ischemic Optic Neuropathy
Neurol 35:112-114, Katz,B.,et al, 1985
Steroid-Responsive Ophthalmoplegia in a Child, Diagnostic Considerations
Arch Neurol 42:589-591, Kandt,R.S.,et al, 1985
Recurrent VI Nerve Palsy in Cluster Headache
Headache 25:325-327, Peatfield,R.C., 1985
The Terminology of Transient Visual Loss Due to Vascular Insufficiency
Stroke 15:907-908, Hedges,T.R., 1984
Prolonged Migraine Aura Status
Ann Neurol 11:197-199, Haas,D.C., 1982
Co-occurring Ophthalmoplegia & Hemiparesis in a Case of Migraine
Arch Neurol 39:445-446, Whitehouse,P.J.,et al, 1982
Migraine Presenting as Acute Confusion & Delirium:A Case Report
Neurol 28:1201, Finelli,P.F., 1978
Episodic Disorders of Vision
MCV Quart 12:99-109, Harbison,J.W., 1976
Visual Symptoms in the Migraine Syndrome
Neurol 23:570, Hachinski,V.,et al, 1973
Isolated Ophthalmic Migraine:Its Frequency, Mechanism & Diff. Diagnosis
Neuro-Ophthalmol 1972-Bascom Palmer Instit Symp, Ed, J. S. Smith., Hedges,T., 1972
Alternating Exophathalmos with Plainful Ophthalmoplegia
Arch Ophthalmol 74:625, Hedges,T., 1965
Ophthalmoplegic Migraine
Arch Neurol 7:320, Friednam,A.P., 1962
Basilar Artery Migraine
Lancet 1:15-17, Bickerstaff,E.R., 1961
Genetic Causes of Cerebral Small Vessel Diseases, A Parctical Guide for Neurologists
Neurol 100:766-783, Manini,A.,&Pantoni,L., 2023
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Factors Associated with Risk of Recurrent Transient Global Amnesia
JAMA Neurol 77:1551-1558, Morris, K.A.,et al, 2020
Cyclic Vomiting Syndrome in Children
AJGH 2:doi:10.33552/AJGH.2020, Al-Ansari, N., 2020
Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients
Stroke 50:283-290, Drazyk, A.M.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Vestibular Migraine
BMJ 366:L4213, Li, V.,et al, 2019
Treatment Effects and Comorbid Diseases in 58 Patients with Visual Snow
Neurol 93:e398-e403, vanDongen, R.M.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019